⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 30, 2024Frontiers in PharmacologyOpen Access

A Bayesian framework for virtual comparative trials and bioequivalence assessments

Frédéric Y. Bois Céline Brochot

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

In virtual bioequivalence (VBE) assessments, pharmacokinetic models informed with

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bois et al. (2024) studied this question.

synapsesocial.com/papers/68e5e7feb6db64358757c6aa https://doi.org/10.3389/fphar.2024.1404619

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design2025 · 3 citations
2Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drugRetrospective Study · 2023 · 11 citations
3Model‐based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?2024 · 6 citations
4Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations2024 · 3 citations
5Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 2. Type 1 Error and Safe space AnalysesOriginal Research · 2026